Toll-like receptor 4 polymorphisms and idiopathic chromosomally normal miscarriage

被引:18
作者
Hirschfeld, A. F.
Jiang, R.
Robinson, W. P.
McFadden, D. E.
Turvey, S. E.
机构
[1] BC Childrens Hosp, Div Infect Dis & Immunol, Dept Paediat, Vancouver, BC V5Z 4H4, Canada
[2] Child & Family Res Inst, Vancouver, BC, Canada
[3] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada
[4] Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 1M9, Canada
关键词
miscarriage; TLR4; polymorphism; innate immunity; lipopolysaccharide;
D O I
10.1093/humrep/del377
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: Lipopolysaccharide (LPS or endotoxin) exposure resulting from microbial invasion of the endometrium disturbs the Th1/Th2 balance at the feto-maternal interface and has been linked to the risk of idiopathic miscarriage in a range of human and animal studies. Toll-like receptor 4 (TLR4) mediates LPS signalling, and the human TLR4 gene harbours two single-nucleotide polymorphisms (SNPs) known to reduce LPS responsiveness. We hypothesized that genetic variation altering TLR4 function may influence the risk of idiopathic pregnancy loss. METHODS AND RESULTS: We examined fetal TLR4 genotypes in a case-control cohort of chromosomally normal miscarriages (n = 96) and healthy term newborns (n = 113). The allele frequencies of the Asp299Gly and Thr399Ile TLR4 SNPs were determined by quantitative PCR using DNA extracted from extraembryonic tissues and umbilical cord blood, respectively. TLR4 genotype frequencies were not significantly different between cases and controls. CONCLUSIONS: There was no association between fetal TLR4 polymorphisms, Asp299Gly and Thr399Ile, known to blunt LPS responsiveness, and the risk of idiopathic, chromosomally normal miscarriage. Nevertheless, TLR4 or perhaps other LPS-binding chaperone molecules are biologically plausible candidate genes that may alter the risk of idiopathic miscarriage.
引用
收藏
页码:440 / 443
页数:4
相关论文
共 45 条
[1]   A role for TLRs in the regulation of immune cell migration by first trimester trophoblast cells [J].
Abrahams, VM ;
Visintin, I ;
Aldo, PB ;
Guller, S ;
Romero, R ;
Mor, G .
JOURNAL OF IMMUNOLOGY, 2005, 175 (12) :8096-8104
[2]   Divergent trophoblast responses to bacterial products mediated by TLRs [J].
Abrahams, VM ;
Bole-Aldo, P ;
Kim, YM ;
Straszewski-Chavez, SL ;
Chaiworapongsa, T ;
Romero, R ;
Mor, G .
JOURNAL OF IMMUNOLOGY, 2004, 173 (07) :4286-4296
[3]   Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections [J].
Agnese, DM ;
Calvano, JE ;
Hahm, SJ ;
Coyle, SM ;
Corbett, SA ;
Calvano, SE ;
Lowry, SF .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (10) :1522-1525
[4]   Association of the toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events [J].
Ameziane, N ;
Beillat, T ;
Verpillat, P ;
Chollet-Martin, S ;
Aumont, MC ;
Seknadji, P ;
Lamotte, M ;
Lebret, D ;
Ollivier, V ;
de Prost, D .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (12) :E61-E64
[5]   TLR4 mutations are associated with endotoxin hyporesponsiveness in humans [J].
Arbour, NC ;
Lorenz, E ;
Schutte, BC ;
Zabner, J ;
Kline, JN ;
Jones, M ;
Frees, K ;
Watt, JL ;
Schwartz, DA .
NATURE GENETICS, 2000, 25 (02) :187-+
[6]  
Baines MG, 1996, AM J REPROD IMMUNOL, V35, P34, DOI 10.1111/j.1600-0897.1996.tb00006.x
[7]   Role of Toll-like receptor 4 in acute myocardial infarction and longevity [J].
Balistreri, CR ;
Candore, G ;
Colonna-Romano, G ;
Lio, D ;
Caruso, M ;
Hoffmann, E ;
Franceschi, C ;
Caruso, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (19) :2339-2340
[8]   Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events [J].
Boekholdt, SM ;
Agema, WRP ;
Peters, RJG ;
Zwinderman, AH ;
van der Wall, EE ;
Reitsma, PH ;
Kastelein, JJP ;
Jukema, JW .
CIRCULATION, 2003, 107 (19) :2416-2421
[9]   Reproductive immunology 2003: reassessing the Th1/Th2 paradigm? [J].
Chaouat, G ;
Ledee-Bataille, N ;
Dubanchet, S ;
Zourbas, S ;
Sandra, O ;
Martal, J .
IMMUNOLOGY LETTERS, 2004, 92 (03) :207-214
[10]  
Clark DA, 1999, AM J REPROD IMMUNOL, V41, P5